Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17505079
[patent_doc_number] => 20220098181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
[patent_app_type] => utility
[patent_app_number] => 17/517428
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517428 | Compositions and methods for inhibition of the JAK pathway | Nov 1, 2021 | Issued |
Array
(
[id] => 17505097
[patent_doc_number] => 20220098199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/504443
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504443 | Synthetic co-crystals of anhydrous guanine and process for preparing the same | Oct 17, 2021 | Issued |
Array
(
[id] => 17385556
[patent_doc_number] => 20220033408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING SPIRO DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/502653
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502653 | PROCESS FOR PREPARING SPIRO DERIVATIVES | Oct 14, 2021 | Abandoned |
Array
(
[id] => 17533555
[patent_doc_number] => 20220112164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => HETEROCYCLIC G-PROTEIN-COUPLED RECEPTOR 52 (GPR52) AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/499299
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499299 | Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists | Oct 11, 2021 | Issued |
17/447805 | DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF | Sep 14, 2021 | |
Array
(
[id] => 18138841
[patent_doc_number] => 20230012676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => TYROSINE KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/465662
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465662 | Tyrosine kinase inhibitors | Sep 1, 2021 | Issued |
Array
(
[id] => 17791975
[patent_doc_number] => 20220251066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/458862
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458862 | SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | Aug 26, 2021 | Abandoned |
Array
(
[id] => 18207813
[patent_doc_number] => 20230054070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SIGMA LIGAND COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/400207
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400207 | Sigma ligand compounds and uses thereof | Aug 11, 2021 | Issued |
Array
(
[id] => 17258433
[patent_doc_number] => 20210371418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => PROTEIN KINASE INHIBITORS, PREPARATION METHOD AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/444109
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444109 | Protein kinase inhibitors, preparation method and medical use thereof | Jul 29, 2021 | Issued |
Array
(
[id] => 17214403
[patent_doc_number] => 20210347740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Prolyl Hydroxylase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/383554
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383554 | Prolyl hydroxylase inhibitors | Jul 22, 2021 | Issued |
Array
(
[id] => 18518441
[patent_doc_number] => 11708319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers
[patent_app_type] => utility
[patent_app_number] => 17/375882
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 18916
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375882 | Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers | Jul 13, 2021 | Issued |
Array
(
[id] => 18559778
[patent_doc_number] => 11725012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Imidazo[1,5-a]pyrazine derivatives as PI3K d inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/370728
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 42268
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370728 | Imidazo[1,5-a]pyrazine derivatives as PI3K d inhibitors | Jul 7, 2021 | Issued |
Array
(
[id] => 18825250
[patent_doc_number] => 11840520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Process for melamine purification
[patent_app_type] => utility
[patent_app_number] => 17/368430
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4136
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368430 | Process for melamine purification | Jul 5, 2021 | Issued |
Array
(
[id] => 18801271
[patent_doc_number] => 11834422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Process for melamine purification
[patent_app_type] => utility
[patent_app_number] => 17/368540
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4125
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368540 | Process for melamine purification | Jul 5, 2021 | Issued |
Array
(
[id] => 17611427
[patent_doc_number] => 20220153706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
[patent_app_type] => utility
[patent_app_number] => 17/356389
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356389 | Inhibitors of lysine specific demethylase-1 | Jun 22, 2021 | Issued |
Array
(
[id] => 17426815
[patent_doc_number] => 20220054523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOUNDS,COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/339484
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339484 | Compounds,compositions, and methods for the treatment of disease | Jun 3, 2021 | Issued |
Array
(
[id] => 17227072
[patent_doc_number] => 20210353628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => TREATMENT OF INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/328772
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328772 | Treatment of inflammatory disorders | May 23, 2021 | Issued |
Array
(
[id] => 18117477
[patent_doc_number] => 11548858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Bioderived epoxide triazine networks and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/324222
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4125
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324222
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324222 | Bioderived epoxide triazine networks and methods of making the same | May 18, 2021 | Issued |
Array
(
[id] => 17081953
[patent_doc_number] => 20210276959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => PROCESS FOR PREPARING 4-AMINO-PYRIDAZINES
[patent_app_type] => utility
[patent_app_number] => 17/323337
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323337 | PROCESS FOR PREPARING 4-AMINO-PYRIDAZINES | May 17, 2021 | Pending |
Array
(
[id] => 18147977
[patent_doc_number] => 20230021834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES
[patent_app_type] => utility
[patent_app_number] => 17/320574
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320574 | Piperidinyl-3-(aryloxy)propanamides and propanoates | May 13, 2021 | Issued |